Ferring Global
The Ferring Group is a privately owned speciality biopharmaceutical company which was first founded in 1950 in Sweden by Dr. Frederik Paulsen.
Ferring now has a presence in more than 60 countries and a workforce in excess of 6,500 employees worldwide. Our presence spans America, Europe, the Middle East and Africa, and Asia Pacific. It currently has production sites in ten countries (Argentina, China, Czech Republic, Denmark, Germany, Israel, Mexico, Scotland, Switzerland, India and the USA). Ferring also has its own Research and Development centres (in China, Denmark, India, Israel and the USA). Ferring currently distributes its products in more than 90 countries.
Further information about the Ferring Group is available at www.ferring.com.
The Ferring Mission Statement
Driven by its entrepreneurial spirit and enabled by a decentralised organisational setup, Ferring will harness its world-class competencies in science and business with other innovative technologies to create solutions for patients and doctors.
By developing an understanding of people’s needs, we will deliver personalised healthcare solutions, integrating pharmaceutical products with diagnostics, data, devices, education and support services to optimise health outcomes.
Ferring will be the world-leading, most trusted healthcare company in reproductive medicine and maternal health, and a leader in specialty areas within gastroenterology and urology. Each of us at Ferring will contribute to providing innovative solutions to help people live better lives. We will devote significant research and development investment to new therapeutics, life cycle management and next generation healthcare solutions.
We are, and continue to be, part of a transparent and aligned company. We strive to best address the needs of patients, stakeholders and customers by collaborating across functions, experimenting and sharing our practices, and continuously learning. We are always guided by the Ferring Philosophy.
Our Corporate Social Responsibility
Corporate Social Responsibility (CSR) is about how we as a Company operate in an ethical and sustainable way and deal with our environmental and social impacts.
Our Therapeutic Areas
As a leader in gastroenterology, Ferring has more than 35 years’ experience in research and providing the right therapies to optimise treatment outcomes for Inflammatory Bowel Disease patients. Ferring is also committed to deepening our understanding of the role of the human microbiome.
We are committed to helping people become parents and to finding innovative, personalised healthcare solutions in reproductive medicine. We offer a portfolio of products for women undergoing infertility treatment.
Ferring has been supplying medicines in obstetrics for over 20 years. The current product portfolio has treatments for induction of labour and prevention of uterine atony in women following Caesarian section.
Ferring has over 50 years of experience in Urology. Our main focus in Urology is on the treatment of prostate cancer and other men’s health-related conditions such as erectile dysfunction. Ferring also provides treatments for nocturnal enuresis and nocturia.